Photo of Kelvin Wyles

Kelvin Wyles

Kelvin serves as national trial counsel and national coordinating counsel in state and federal courts from coast to coast. Kelvin has tried cases across the country and collaborates with medical, scientific and other subject-matter experts to assist clients in defending national portfolios of asbestos litigation claims. Kelvin’s knowledge of medicine and science is broad and deep. He works closely with experts who are leaders in fields of pathology, pulmonology, industrial hygiene, epidemiology, immunology and genetics, and he has particular interest and knowledge in genetic-related cases and the science related thereto. Product manufacturers and distributors in construction, safety and automotive sectors are among those relying on his guidance. Kelvin has also argued in in the court of appeals on behalf of clients.

Kelvin’s more than 25 years of extensive experience in trial, litigation and appellate matters includes catastrophic injury, environmental issues, product liability and toxic torts, including advocating for clients regarding regulatory issues before the Environmental Protection Agency (EPA). Kelvin has experience with commercial litigation, contract disputes, leasing and construction defect disputes, real estate contracts, class action litigation, and trade secret and intellectual property matters.

Prior to making the United States his home, Kelvin practiced as a solicitor for the law firm of Freshfields, Bruckhaus, Deringer in London, England.

BAP1 as Independent Cause

Recent reviews of genetic research continue to challenge long-held assumptions about the causes of malignant mesothelioma. While plaintiffs’ attorneys often cite to asbestos exposure as the only cause of mesothelioma, a January 2025 publication in Scientific Reports led by Dahlia Nielsen includes a novel approach to the subject and provides further evidence that certain inherited genetic mutations—most notably in the BAP1 gene—can independently cause mesothelioma, even in the absence of asbestos exposure.1 The results of Nielsen’s Bayesian analysis and findings, together with a brand new paper2 by Dr. Michele Carbone’s group (which may find its way into a future blog), may alter the landscape of asbestos litigation and influence the strategies used by both plaintiffs and defendants.